Cargando…
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
BACKGROUND: Disseminated thrombotic process in the microcirculation is considered to be an important cause of multiple organ dysfunction in sepsis. The fundamental purpose of this prothrombotic change was believed to be in the host defense against microbial dissemination. In that process, antifibrin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585957/ https://www.ncbi.nlm.nih.gov/pubmed/28904799 http://dx.doi.org/10.1186/s40560-017-0250-z |
_version_ | 1783261725213065216 |
---|---|
author | Iba, Toshiaki Thachil, Jecko |
author_facet | Iba, Toshiaki Thachil, Jecko |
author_sort | Iba, Toshiaki |
collection | PubMed |
description | BACKGROUND: Disseminated thrombotic process in the microcirculation is considered to be an important cause of multiple organ dysfunction in sepsis. The fundamental purpose of this prothrombotic change was believed to be in the host defense against microbial dissemination. In that process, antifibrinolytic property plays an important role. MAIN BODY: For the understanding of pathophysiology of sepsis, it is quite useful to grasp the alterations in coagulation/fibrinolytic parameters, i.e., plasminogen activator and plasminogen activator inhibitor-1. They play crucial roles in the development of clot formation and disseminated intravascular coagulation that leads to fatal organ dysfunction. Basically, fibrinolysis is a simple system compared to the complex coagulation cascade. Plasmin is the only factor that regulates fibrinolysis, and this enzyme is modulated by several factors including plasminogen activators and plasminogen activator inhibitor-1. However, recent studies have elucidated the complex regulation of the production, activation, and inactivation of these fibrinolytic factors. CONCLUSION: The dynamic change of the fibrinolytic system plays a crucial role in the pathophysiology of sepsis. In this commentary, we introduce the recent advances of the research regarding fibrinolytic system. |
format | Online Article Text |
id | pubmed-5585957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55859572017-09-13 Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis Iba, Toshiaki Thachil, Jecko J Intensive Care Commentary BACKGROUND: Disseminated thrombotic process in the microcirculation is considered to be an important cause of multiple organ dysfunction in sepsis. The fundamental purpose of this prothrombotic change was believed to be in the host defense against microbial dissemination. In that process, antifibrinolytic property plays an important role. MAIN BODY: For the understanding of pathophysiology of sepsis, it is quite useful to grasp the alterations in coagulation/fibrinolytic parameters, i.e., plasminogen activator and plasminogen activator inhibitor-1. They play crucial roles in the development of clot formation and disseminated intravascular coagulation that leads to fatal organ dysfunction. Basically, fibrinolysis is a simple system compared to the complex coagulation cascade. Plasmin is the only factor that regulates fibrinolysis, and this enzyme is modulated by several factors including plasminogen activators and plasminogen activator inhibitor-1. However, recent studies have elucidated the complex regulation of the production, activation, and inactivation of these fibrinolytic factors. CONCLUSION: The dynamic change of the fibrinolytic system plays a crucial role in the pathophysiology of sepsis. In this commentary, we introduce the recent advances of the research regarding fibrinolytic system. BioMed Central 2017-09-06 /pmc/articles/PMC5585957/ /pubmed/28904799 http://dx.doi.org/10.1186/s40560-017-0250-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Iba, Toshiaki Thachil, Jecko Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis |
title | Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis |
title_full | Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis |
title_fullStr | Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis |
title_full_unstemmed | Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis |
title_short | Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis |
title_sort | clinical significance of measuring plasminogen activator inhibitor-1 in sepsis |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585957/ https://www.ncbi.nlm.nih.gov/pubmed/28904799 http://dx.doi.org/10.1186/s40560-017-0250-z |
work_keys_str_mv | AT ibatoshiaki clinicalsignificanceofmeasuringplasminogenactivatorinhibitor1insepsis AT thachiljecko clinicalsignificanceofmeasuringplasminogenactivatorinhibitor1insepsis |